# Lyell Immunopharma, Inc.: Form 8-K, filed May 6, 2024

- Company: [Lyell Immunopharma, Inc.](/companies/lyel.md) (CIK 1806952)
- Form: 8-K
- Filed: 2024-05-06
- Accepted by EDGAR: May 6, 2024, 08:03 ET
- Period: 2024-05-06
- Accession: 0001628280-24-020466
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1806952/000162828024020466/lyel-20240506.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1806952/000162828024020466/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1806952/000162828024020466/lyel-20240506.htm

Filed May 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-020466. Last ingested by Listed: Nov 4, 2026, 17:25 ET. No prices; not investment advice.